Health authorities around the world have received a new roadmap for addressing obesity, as the World Health Organisation released its first guideline on the use of GLP-1 therapies for treating the condition.
The move arrives at a time when obesity, already affecting more than one billion people, continues to climb, straining both health systems and household wellbeing.
WHO notes that obesity has become one of the most significant contributors to poor health worldwide.
